Stay updated on Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.

Latest updates to the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference2%
- Check19 days agoChange DetectedMinor version update added; several drug-safety and pharmaceutical topics were removed, narrowing the page’s scope around medications and safety topics.SummaryDifference0.6%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed; overall core content remains unchanged.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check48 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of new resources related to genetic diseases and drug safety. Notably, previous entries for certain locations have been removed, indicating a refinement in the information presented.SummaryDifference7%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.